Takeda and Orexigen receive FDA approval for new weight-loss pill called Contrave
Takeda Pharmaceuticals USA and Orexigen Therapeutics have received approval from the US Food and Drug Administration (FDA) for a ...
Takeda Pharmaceuticals USA and Orexigen Therapeutics have received approval from the US Food and Drug Administration (FDA) for a ...
Milwaukee-based pharmacy chain Hayat Pharmacy will open its sixth location Tuesday at its first site in southern Milwaukee County: 4931 ...
Milwaukee-based pharmacy chain Hayat Pharmacy will open its sixth location Tuesday at its first site in southern Milwaukee County: 4931 ...
Rock Creek Pharmaceuticals, Inc., a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today it has ...
Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration (FDA) has ...
The USA’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for HIV/AIDS treatment and prevention, according to the ...
Mettler Toledo has initiated a collaboration with Actera Pharmaceuticals, San Francisco, to expand the applications of Focused Beam Reflectance Measurement ...
Mylan Inc. today announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, ...
Actavis plc today confirmed that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has ...
Baxter International Inc. announced today that Baxalta Incorporated will be the name of the new, publicly traded biopharmaceutical company that ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
